← Leaderboards
Matthew H. Liang
Brigham And Women'S Hospital
$481,226
Attributed
$481,226
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$4,678,181 · 7
By mechanism
P60$4,500,556 · 4
R21$127,125 · 1
R13$50,500 · 2
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Jeffrey Neil Katz$23,923,428
- Dae Hyun Kim$10,266,963
- Eva S. Liu$2,877,569
- Rong Tian$29,765,984
- Robert J Glynn$12,512,252
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchSystemic Lupus ErythematosusDisease /Disorder Proneness /RiskArthritisPatient Care ManagementChemopreventionCardiovascular Disorder PreventionHuman Therapy EvaluationTelemedicineAtherosclerosisClinical TrialsRheumatoid ArthritisBehavioral /Social Science Research TagPatient Oriented ResearchOrphan Disease /DrugMusculoskeletal DisorderOutcomes ResearchCardiovascular AgentsLyme DiseaseCommunicable Disease ControlDisease /Disorder Prevention /ControlEducation Evaluation /PlanningLifestyle
Grant awards (11)
LUPUS 2010: Ninth International Congress on Systemic Lupus Erythematosus$30,000
R13 · FY2010 · AR · contact PI
NIAMS MULTIDISCIPLINARY CLINICAL RESEARCH CENTER$1,341,929
P60 · FY2002 · AR
Trial of risk mangement for prevention of accelerated atherosclerosis in SLE$0
P60 · FY2002 · AR
NIAMS MULTIDISCIPLINARY CLINICAL RESEARCH CENTER$1,339,171
P60 · FY2001 · AR
Conference--Standards for Treatment of SLE Patients$20,500
R13 · FY2001 · AR
Trial of risk mangement for prevention of accelerated atherosclerosis in SLE$0
P60 · FY2001 · AR
MULTIPURPOSE ARTHRITIS &MUSCULOSKELETAL DISEASES CENTER$1,405,805
P60 · FY2000 · AR
CONTROLLED TRIAL OF PRIMARY AND SECONDARY PREVENTION PROGRAM FOR LYME DISEASE$157,130
P60 · FY2000 · AR
CONTROLLED TRIAL OF PRIMARY AND SECONDARY PREVENTION PROGRAM FOR LYME DISEASE$146,471
P60 · FY2000 · AR
RCT OF PREVENTION OF ACCELERATED ATHEROSCLEROSIS IN SLE$127,125
R21 · FY2000 · AR
MULTIPURPOSE ARTHRITIS &MUSCULOSKELETAL DISEASES CENTER$110,050
P60 · FY2000 · AR